![Thomas Stankovich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Stankovich
Finanzdirektor/CFO bei
ReShape Weightloss, Inc.
Profil
Thomas Stankovich is currently Chief Financial Officer & Senior Vice President at ReShape Weightloss, Inc. since 2019.
Former roles include President, Chief Executive Officer, CFO & CAO at ReShape Lifesciences, Inc. in 2022; Chief Financial Officer & Senior Vice President at Ribapharm, Inc. from 2001 to 2003; Chief Financial Officer, Treasurer & EVP at Cobalis Corp.
from 2005 to 2006; Chief Financial Officer, Secretary & VP at Response Genetics, Inc. from 2006 to 2010; Chief Financial Officer & Secretary at Obalon Therapeutics, Inc.; Chief Financial Officer & Senior Vice President at MP Biomedicals LLC from 2003 to 2005; Chief Financial Officer & Vice President at ICN International AG from 2000 to 2001; Head-Controlling & Vice President at ICN from 1986 to 2011; and Chief Financial Officer at Vyome Holdings, Inc. Education includes undergraduate studies at California State University-Northridge.
Aktive Positionen von Thomas Stankovich
| Unternehmen | Position | Beginn |
|---|---|---|
ReShape Weightloss, Inc.
 ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Finanzdirektor/CFO | 30.10.2019 |
Ehemalige bekannte Positionen von Thomas Stankovich
| Unternehmen | Position | Ende |
|---|---|---|
| RESPONSE GENETICS, INC | Finanzdirektor/CFO | 02.04.2010 |
Cobalis Corp.
 Cobalis Corp. Pharmaceuticals: OtherHealth Technology Develops anti allergy medications | Finanzdirektor/CFO | 18.12.2006 |
MP Biomedicals LLC
 MP Biomedicals LLC BiotechnologyHealth Technology Manufactures and sells biotechnology research products | Finanzdirektor/CFO | 01.12.2005 |
Ribapharm, Inc.
 Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets antiviral and anticancer pharmaceuticals | Finanzdirektor/CFO | 01.01.2003 |
ICN International AG | Finanzdirektor/CFO | 01.01.2001 |
Ausbildung von Thomas Stankovich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Ribapharm, Inc.
Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets antiviral and anticancer pharmaceuticals | Health Technology |
Cobalis Corp.
Cobalis Corp. Pharmaceuticals: OtherHealth Technology Develops anti allergy medications | Health Technology |
Response Genetics, Inc.
 Response Genetics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical and diagnostic services | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy | Health Technology |
MP Biomedicals LLC
MP Biomedicals LLC BiotechnologyHealth Technology Manufactures and sells biotechnology research products | Health Technology |
California State University-Northridge
 California State University-Northridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ICN International AG | |
ICN/DN Europe | |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Health Technology |
ReShape Lifesciences, Inc.
 ReShape Lifesciences, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of obesity | Health Technology |
